Sutro Biopharma, Inc. (STRO)
25.29
+2.79
(+12.40%)
USD |
NASDAQ |
Mar 06, 16:00
25.24
-0.05
(-0.20%)
After-Hours: 20:00
Sutro Biopharma Cash from Investing (TTM) : 113.80M for Sept. 30, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| GT Biopharma, Inc. | 0.00 |
| Rhythm Pharmaceuticals, Inc. | -137.15M |
| Crinetics Pharmaceuticals, Inc. | 173.91M |
| ACADIA Pharmaceuticals, Inc. | -302.56M |
| Alnylam Pharmaceuticals, Inc. | 436.33M |